Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: |
Title | Abera Bioscience | Platform and vaccine |
Description | Next Generation Abera is developing the next generation vaccines and immunotherapies based on our proprietary vaccine delivery |
Keywords | N/A |
WebSite | aberabio.com |
Host IP | 91.201.62.219 |
Location | Sweden |
Site | Rank |
US$2,835,181
Last updated: 2023-05-18 05:20:33
aberabio.com has Semrush global rank of 3,733,203. aberabio.com has an estimated worth of US$ 2,835,181, based on its estimated Ads revenue. aberabio.com receives approximately 327,137 unique visitors each day. Its web server is located in Sweden, with IP address 91.201.62.219. According to SiteAdvisor, aberabio.com is safe to visit. |
Purchase/Sale Value | US$2,835,181 |
Daily Ads Revenue | US$2,618 |
Monthly Ads Revenue | US$78,513 |
Yearly Ads Revenue | US$942,153 |
Daily Unique Visitors | 21,810 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
aberabio.com. | A | 599 | IP: 91.201.62.219 |
aberabio.com. | NS | 14400 | NS Record: ns02.one.com. |
aberabio.com. | NS | 14400 | NS Record: ns01.one.com. |
aberabio.com. | MX | 3600 | MX Record: 10 aspmx2.googlemail.com. |
aberabio.com. | MX | 3600 | MX Record: 5 alt2.aspmx.l.google.com. |
aberabio.com. | MX | 3600 | MX Record: 1 aspmx.l.google.com. |
aberabio.com. | MX | 3600 | MX Record: 10 aspmx5.googlemail.com. |
aberabio.com. | MX | 3600 | MX Record: 5 alt1.aspmx.l.google.com. |
aberabio.com. | MX | 3600 | MX Record: 10 aspmx4.googlemail.com. |
aberabio.com. | MX | 3600 | MX Record: 10 aspmx3.googlemail.com. |
info@aberabio.com About Abera About us Management Board of directors Advisory board Career Technology Projects News Investors The Share Financial Reports External financial analysis Presentations Annual General Meeting 2023 Shareholders Corporate Governance Investor Relation Contact Contact Contact us Partner & Licensing Menu About Abera About us Management Board of directors Advisory board Career Technology Projects News Investors The Share Financial Reports External financial analysis Presentations Annual General Meeting 2023 Shareholders Corporate Governance Investor Relation Contact Contact Contact us Partner & Licensing Next Generation vaccines Abera is developing the next generation vaccines and immunotherapies based on our proprietary vaccine delivery platform. Read about our technology Technology Abera’s proprietary vaccine delivery platform – BERA, enables high-level multivalent presentation of recombinant antigens on bacterial Outer Membrane Vesicles (OMVs) for strong |
HTTP/1.1 301 Moved Permanently Connection: Keep-Alive Keep-Alive: timeout=5, max=100 date: Thu, 26 May 2022 14:42:09 GMT server: LiteSpeed location: https://aberabio.com/ vary: Accept-Encoding HTTP/2 200 x-powered-by: PHP/7.4.29 last-modified: Thu, 26 May 2022 05:34:39 GMT content-type: text/html; charset=UTF-8 cache-control: public, max-age=0 expires: Thu, 26 May 2022 14:42:09 GMT date: Thu, 26 May 2022 14:42:09 GMT server: LiteSpeed vary: Accept-Encoding alt-svc: h3=":443"; ma=2592000, h3-29=":443"; ma=2592000, h3-Q050=":443"; ma=2592000, h3-Q046=":443"; ma=2592000, h3-Q043=":443"; ma=2592000, quic=":443"; ma=2592000; v="43,46" |
Domain Name: ABERABIO.COM Registry Domain ID: 1755610398_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.rrpproxy.net Registrar URL: http://www.key-systems.net Updated Date: 2021-02-15T05:21:02Z Creation Date: 2012-10-29T15:56:54Z Registry Expiry Date: 2022-10-29T15:56:54Z Registrar: Key-Systems GmbH Registrar IANA ID: 269 Registrar Abuse Contact Email: abuse@key-systems.net Registrar Abuse Contact Phone: +49.68949396850 Domain Status: ok https://icann.org/epp#ok Name Server: NS01.ONE.COM Name Server: NS02.ONE.COM DNSSEC: unsigned >>> Last update of whois database: 2022-05-26T14:47:18Z <<< |